Empirico Inc. comprises of biologists, physicians, chemists, data scientists and drug developers whose focus is on transforming patients' lives with innovative therapies.
By combining genetic data with health information from millions of individuals, the company learns about the role of genes and proteins in health and disease, and finds opportunities for novel therapeutic interventions.
Its Precision Insights Platform™ was purpose-built for target discovery. By combining expert data curation, customized data models and proprietary algorithms, the platform enables its scientists to systematically generate, interrogate, and prioritize high-confidence therapeutic hypotheses. Its platform is built on large amounts of data from thousands of studies and millions of individuals, and it is one of the largest datasets of its kind in the world.
By combining internal expertise with a network of partners and collaborators, the company aims to pair each novel target with its optimal translational approach.